Journal
JOURNAL OF VETERINARY MEDICAL SCIENCE
Volume 83, Issue 3, Pages 456-460Publisher
JAPAN SOC VET SCI
DOI: 10.1292/jvms.20-0464
Keywords
cat; chemotherapy; nasal lymphoma; prognosis; radiotherapy
Categories
Funding
- Japan Society for the Promotion of Science, KAKENHI [20H03143, 15K18797]
- Grants-in-Aid for Scientific Research [20H03143, 15K18797] Funding Source: KAKEN
Ask authors/readers for more resources
The study indicated that similar efficacy could be achieved by palliative hypofractionated radiotherapy, chemotherapy, or a combination of them for nasal lymphoma in cats, with no significant difference in overall survival and progression free survival among these three treatment groups.
Nasal lymphoma (NL) is the most common nasal tumor in cats, and radiotherapy, chemotherapy, or a combination of these treatments have been described as the treatment for this disease. However, the previous studies included various machines and protocols of radiotherapy. Therefore, we aimed to retrospectively compare the prognosis among cases treated with palliative hypofractionated radiotherapy, chemotherapy, and a combination of them with united machine and protocol of radiotherapy. When compared overall survival and progression free survival, there was no significant difference among these three groups. The data of this study suggested that similar efficacy could be achieved by palliative hypofractionated radiotherapy, chemotherapy, or a combination of them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available